Opinions on Celgene Corp. (NASDAQ-GS:CELG)
| Change: | -0.69 (-0.99%) |
| Last Trade: | 69.30 |
| Market Cap: | 32.50B |
| Price/earning ratio: | N/A |
| Share Volume: | 2,553,297 |
| Dividend yield: | N/A |
| Short % of float: | 2.70% |
| Beta: | 0.24 |
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Top 2%
May 18 at 3:03 ET
Genentech has shown great great returns over the past 5 years Return on Equity nearly 20% and return on capital over 15%. over the past 10 years sales are up 25%/year One of their major products Avastin has been approved in the treament of various canc...
Top 1%
Apr 06 at 3:24 ET
extra strong results for this company.. seems like chart performance is oblivious to the recent market decline... this stock is definitely going on my Tracklist.
Top 1%
Dec 13 2007 at 8:22 ET
selling CELG after hitting a SellStop... came out of this kind of even but just as well..
CELG Opinions
- Post a new opinion
- Recently Posted
- Private Notes
- Portfolio
- Portfolio Watchlist
- Gurus
- Track List
- My Opinions
Sort By Date | Rank